REGN
$597.62
Regeneron Pharmaceuticals
$3.20
.54%
REGN
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus: $9.94
Revenue: $2.81 Bil
Share
Watch
Latest EPS
Wednesday, May 4, 2022
What do you expect when REGN reports earnings?
Where is REGN's stock price going from here?
Analysts
Pivots
Resistance
$624.08
$615.75
$606.68
Support
$589.28
$580.95
$571.88
Description
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.